1002752-53-5 Usage
Uses
Used in Pharmaceutical Industry:
(S)-4-benzyl-3-((S)-2-(3-broMophenyl)-3-(4-chlorophenyl)propanoyl)oxazolidin-2-one is used as a potential antibacterial agent due to its classification within the oxazolidinone class of compounds. Its unique molecular structure, which includes aromatic groups and the oxazolidinone ring, may contribute to its effectiveness in combating bacterial infections.
Used in Research and Development:
(S)-4-benzyl-3-((S)-2-(3-broMophenyl)-3-(4-chlorophenyl)propanoyl)oxazolidin-2-one is also used in the research and development of new pharmaceuticals, particularly in the field of medicinal chemistry. Its structure and potential biological activity make it a valuable candidate for further study and analysis, with the aim of discovering new therapeutic applications and improving existing treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 1002752-53-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,2,7,5 and 2 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1002752-53:
(9*1)+(8*0)+(7*0)+(6*2)+(5*7)+(4*5)+(3*2)+(2*5)+(1*3)=95
95 % 10 = 5
So 1002752-53-5 is a valid CAS Registry Number.
1002752-53-5Relevant articles and documents
Convenient total synthesis of taranabant (MK-0364), a novel cannabinoid-1 receptor inverse agonist as an anti-obesity agent
Kim, Min-ah,Kim, Jong Yup,Song, Kwang-Seop,Kim, Jeongmin,Lee, Jinhwa
, p. 12845 - 12852 (2007)
Being obese has various health problems that are related to type 2 diabetes mellitus, cardiovascular disease, hypertension, hyperlipidemia, and fibrinolytic abnormalities. Merck's taranabant (MK-0364), a CB1R inverse agonist, is currently in Phase 3 clini